Tag: genome editing therapeutic platform

New funding opportunity from NIH: IND-enabling Studies for Platform Clinical Trials of Genome Editing in Multiple Diseases

The US National Institutes of Health (NIH) published a new Notice of Funding Opportunity (NOFO) with the aim to provide support for applications for IND-enabling studies for the development of a novel in vivo genome editing therapeutic platform (genome editor plus delivery system) for two or more disease indications, using the same genome editor, route of administration, and […]

Read More